AYRO Inc (AYRO) Estimation And Forecast
AYRO Inc (NASDAQ:AYRO) has a beta value of 3.46 and has seen 1.26 million shares traded in the recent trading session. The company, currently valued
AYRO Inc (NASDAQ:AYRO) has a beta value of 3.46 and has seen 1.26 million shares traded in the recent trading session. The company, currently valued
United Micro Electronics ADR (NYSE:UMC) has a beta value of 1.07 and has seen 1.3 million shares traded in the recent trading session. The company,
KE Holdings Inc ADR (NYSE:BEKE) has a beta value of -0.75 and has seen 2.01 million shares traded in the recent trading session. The company,
BriaCell Therapeutics Corp (NASDAQ:BCTX) has a beta value of 1.31 and has seen 3.7 million shares traded in the recent trading session. The company, currently
Revolution Medicines Inc (NASDAQ:RVMD) has a beta value of 1.10 and has seen 1.02 million shares traded in the recent trading session. The company, currently
EQT Corp (NYSE:EQT) has a beta value of 0.66 and has seen 1.22 million shares traded in the recent trading session. The company, currently valued
Conoco Phillips (NYSE:COP) has a beta value of 0.61 and has seen 1.67 million shares traded in the recent trading session. The company, currently valued
Snowflake Inc (NYSE:SNOW) has a beta value of 1.21 and has seen 2.3 million shares traded in the recent trading session. The company, currently valued
Clarivate Plc (NYSE:CLVT) has a beta value of 1.48 and has seen 3.25 million shares traded in the recent trading session. The company, currently valued
DLocal Limited (NASDAQ:DLO) has a beta value of 1.10 and has seen 1.18 million shares traded in the recent trading session. The company, currently valued
© 2024, Powered by Smart TechOne